Wenzhou Duoliang v. Colgate-Palmolive: Oral Care Patent Dismissed With Prejudice in 34 Days
Five Wenzhou-based Chinese trading entities sued Colgate-Palmolive in the Southern District of New York over US8734042B2, a patent covering oral care implements with rapid flavor release technology. The parties reached a stipulated dismissal with prejudice in just 34 days — before a scheduled TRO hearing could take place — with each side bearing its own costs.
Chinese trade entities v. Colgate: a 34-day patent skirmish over flavored oral care
Filed on 9 October 2025 in the Southern District of New York before Judge P. Kevin Castel, this patent infringement action was brought by five affiliated Wenzhou-based entities — Wenzhou Duoliang International Trade Co., Ltd. and four related trading and food technology companies — against Colgate-Palmolive Company. The asserted patent, US8734042B2, relates to an oral care implement engineered for rapid flavor release, a technology segment directly relevant to Colgate’s core consumer product lines.
The case ended on 12 November 2025 via a stipulated dismissal with prejudice under Federal Rule of Civil Procedure 41(a)(1)(A)(ii). Critically, a TRO hearing had been scheduled for 13 November 2025 — just one day after the dismissal was filed — suggesting the parties resolved the matter on the eve of that hearing. Dismissal with prejudice permanently bars the plaintiffs from re-asserting the same claims against Colgate, and the cost-neutral arrangement means no monetary award changed hands as part of the court record.
The 34-day lifespan is notably short even for cases that settle early, and the proximity to the TRO deadline suggests that either the imminent hearing created settlement pressure or the parties had reached commercial terms prior to filing. The public record does not disclose any licensing agreement, financial settlement, or other underlying terms. Whether the dismissal reflects a broader commercial resolution — or simply a recognition that the TRO was unlikely to succeed — remains unknown from publicly available docket information.
Filing to Dismissed with Prejudice in 34 days
34 days — resolved before first hearing, well under typical S.D.N.Y. patent case timelines
Dismissed with prejudice: what the stipulated exit means for both parties
Rule 41(a)(1)(A)(ii) dismissal with prejudice explained
A stipulated dismissal under Rule 41(a)(1)(A)(ii) requires agreement of all parties and, when filed with prejudice, carries the force of a final adjudication on the merits. Plaintiffs permanently relinquish the right to re-litigate these specific claims against Colgate-Palmolive. No court ruling on validity or infringement was issued — the case ended by mutual agreement, not judicial determination.
Permanent bar on re-filingPlaintiffs lose the right to sue Colgate on this patent again
By stipulating to dismissal with prejudice, the five Wenzhou entities have extinguished their infringement claims against Colgate-Palmolive under US8734042B2. They retain ownership of the patent and may enforce it against other parties, but the with-prejudice designation means they cannot reinstate or refile this specific action against Colgate. Any underlying commercial terms remain undisclosed in the public record.
Claims extinguished vs. ColgateColgate exits without a validity ruling — but with permanent dismissal protection
Colgate-Palmolive secured a with-prejudice dismissal, providing durable protection against these specific plaintiffs reasserting US8734042B2 claims. Colgate did not obtain a ruling that the patent is invalid or not infringed, so the patent itself remains in force. Colgate bears its own costs, which is consistent with a negotiated exit rather than a litigation win. The TRO threat is fully extinguished.
Protected from re-suit by these plaintiffsPatent survives; third-party oral care players remain exposed
US8734042B2 remains an active, enforceable patent. The dismissal with prejudice resolves only the Colgate dispute — other oral care manufacturers, private-label producers, or importers of flavored oral care implements are not protected by this outcome. Companies in the rapid flavor release oral care segment should monitor the patent’s enforcement history, particularly given the plaintiff group’s apparent willingness to assert aggressively and then resolve quickly.
Patent still enforceable vs. othersFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | WenzhouDuoliang International Trade Co., Ltd. | Company | Chinese oral care and trading group — holder of US8734042B2 (rapid flavor release implement)Search in Eureka ↗ |
| Defendant | Colgate Palmolive Compagny | Individual | Colgate-Palmolive Company — global consumer goods company; oral care market leaderSearch in Eureka ↗ |
| Plaintiff counsel | Alexander Warden | Attorney | Counsel for WenzhouDuoliang International Trade Co., Ltd.Search in Eureka ↗ |
| Plaintiff law firm | West Atlantic Law Firm, PLLC. | Law Firm | Representing WenzhouDuoliang International Trade Co., Ltd.Search in Eureka ↗ |
| Defendant counsel | Brooke Wilner | Attorney | Counsel for Colgate Palmolive CompagnySearch in Eureka ↗ |
| Defendant counsel | Hannah Yael Shay Chanoine | Attorney | Counsel for Colgate Palmolive CompagnySearch in Eureka ↗ |
| Defendant counsel | Robert F. Shaffer | Attorney | Counsel for Colgate Palmolive CompagnySearch in Eureka ↗ |
| Defendant law firm | O’melveney & Myers LLP | Law Firm | Representing Colgate Palmolive CompagnySearch in Eureka ↗ |
| Presiding judge | Judge P. Kevin Castel | Judge | New York Southern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulated dismissal language is precise: all claims against Colgate are dismissed with prejudice under Rule 41(a)(1)(A)(ii), with costs neutralised. The with-prejudice designation is legally significant — it operates as a final judgment on the merits for preclusion purposes, foreclosing any future action by these plaintiffs on the same claims. Notably, no court assessed patent validity, claim scope, or infringement likelihood, meaning the patent’s enforceability against third parties is entirely unaffected by this outcome.
US8734042B2 — Oral care implement with rapid flavor release
US8734042B2 (Application No. US13/077446) protects an oral care implement designed to release flavouring agents rapidly during use — a technology relevant to toothbrushes, tongue cleaners, or related devices incorporating flavour-delivery mechanisms. The patent addresses a functional problem in consumer oral care: maintaining or enhancing sensory experience during the brushing process through controlled flavour release. Its grant represents a protectable innovation boundary in a segment where consumer experience differentiation drives product value.
For a global oral care leader such as Colgate-Palmolive, any patent asserting rapid flavour release functionality in an implement is commercially material. Colgate’s product portfolio spans toothbrushes and oral care accessories where such features are used as brand differentiators. Competitors and private-label manufacturers sourcing flavoured oral care implements — particularly those importing from Chinese manufacturers — should assess whether their products fall within the claim scope of US8734042B2, as the patent holder has now demonstrated willingness to assert in US federal court.
Should your product team run an FTO against US8734042B2?
Any company designing, importing, distributing, or retailing oral care implements that incorporate flavour-infused or rapid-release flavouring mechanisms should treat US8734042B2 as a live risk. The patent has been asserted against one of the world’s largest oral care companies, and a with-prejudice dismissal protects only Colgate. Private-label brands, OEM manufacturers, and e-commerce importers of flavoured toothbrushes or similar products are not shielded by this outcome.
PatSnap Eureka’s FTO Search Agent can map your product’s feature set against the claims of US8734042B2, identify prior art that may support a validity challenge, and surface any continuation or family patents filed by the Wenzhou entity group. For R&D and product teams developing next-generation oral care implements, running a targeted FTO now — before commercial launch — is significantly less costly than defending a TRO application in S.D.N.Y.
Run a freedom-to-operate analysis on US8734042B2 to assess your product’s exposure
Run FTO in Eureka →Similar oral care patent infringement cases in S.D.N.Y. and U.S. federal courts
Browse comparable patent infringement actions involving oral care implement technology filed in the Southern District of New York and related U.S. federal courts.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Oral care implement with rapid flavor release-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedWenzhouDuoliang International Trade Co., Ltd.’s broader IP enforcement history
WenzhouDuoliang International Trade Co., Ltd.’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the oral care and consumer IP landscape
A 34-day lifecycle and eve-of-TRO settlement pattern is a recognisable litigation tactic worth understanding.
Short lifecycle before a TRO hearing is a classic pressure-filing pattern
Filing for a TRO and then dismissing the day before the hearing is a well-documented tactic in IP litigation. It can reflect a genuine commercial resolution, or it may signal that the movant assessed the TRO as unlikely to succeed on the merits. Oral care companies facing similar filings should note the speed of the exit and evaluate whether the underlying patent represents a credible threat.
US8734042B2 remains live — other oral care defendants are not protected
The with-prejudice dismissal binds only these parties. Any manufacturer, importer, or retailer of oral care implements with rapid flavor release technology remains potentially exposed to assertion by the Wenzhou entity group. Companies operating in this product category should assess their FTO posture against this patent before the next enforcement action is filed.
Wenzhou entity structure suggests a coordinated assertion strategy
Five related entities appearing as co-plaintiffs — spanning trading, food technology, and import functions — is consistent with structured IP assertion by a Chinese corporate group. This filing pattern suggests the patent may be part of a broader cross-border enforcement campaign, not a one-off dispute. Monitoring related entity filings in other US districts is advisable for players in the oral care implements space.
Cost-neutral exit may mask undisclosed licensing terms — watch for SEP-style follow-ons
A ‘each side bears own costs’ settlement in a with-prejudice dismissal does not preclude a confidential licensing payment or cross-licensing arrangement. In Chinese-plaintiff assertion cases, public dismissals have sometimes followed private royalty agreements. IP counsel advising oral care brands should factor in the possibility that a licensing precedent was set, even if it is not visible in the court record.
WenzhouDuoliang v Colgate — key questions answered
Dismissal with prejudice under Rule 41(a)(1)(A)(ii) means the five Wenzhou plaintiff entities permanently relinquish their infringement claims against Colgate-Palmolive under US8734042B2. They cannot refile this action or reassert the same claims against Colgate. The patent itself remains valid and enforceable against other parties.
The asserted patent is US8734042B2 (Application No. US13/077446), covering an oral care implement with rapid flavor release. The case was filed in the Southern District of New York on 9 October 2025 and dismissed with prejudice on 12 November 2025.
The case was filed on 9 October 2025 and the parties stipulated to dismissal on 12 November 2025, one day before a scheduled TRO hearing. The public record does not disclose the reasons. The eve-of-hearing timing is consistent with either a negotiated commercial resolution or the plaintiffs concluding the TRO application was unlikely to succeed on the merits.
No. The with-prejudice dismissal in case 1:25-cv-08395 applies only to the parties to this action. Other manufacturers, importers, or retailers of oral care implements incorporating rapid flavor release technology remain fully exposed to potential infringement assertions by the Wenzhou patent holder group under US8734042B2.
The plaintiff entities were represented by Alexander Warden of West Atlantic Law Firm, PLLC. Colgate-Palmolive was represented by Brooke Wilner, Hannah Yael Shay Chanoine, and Robert F. Shaffer of O’Melveny & Myers LLP. Judge P. Kevin Castel presided over the case in the Southern District of New York.
Monitor US8734042B2 and protect your oral care product portfolio
US8734042B2 is live and has been asserted in federal court. Run an FTO before your next product launch and set alerts for new enforcement filings by the Wenzhou entity group across all US districts.
PatSnap Eureka searches patents and litigation data to answer instantly.